Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

NCT00779285 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Pegylated Liposomal Doxorubicin

Sponsor

Merck Sharp & Dohme LLC